Evidence map›Paper›PMID 42043746›Full record

ArticleEndocrine2026

The effectiveness of levothyroxine starting doses after thyroidectomy is compromised by early body variations occurring after surgery.

Pierpaolo Trimboli, Pietro Giacopelli, Martina Zandonà, Verdiana Caironi, Chiara Camponovo, Elena Gamarra, Lauro Gianola, Barbara Lucchini, Marco Centanni, Mario Rotondi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pierpaolo TrimboliThyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. pierpaolo.trimboli@eoc.ch.ORCID 0000-0002-2125-4937
Pietro GiacopelliService of Surgery, Regional Hospital of Mendrisio, Ente Ospedaliero Cantonale, Mendrisio, Switzerland.
Martina ZandonàDepartment of Internal Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Verdiana CaironiThyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Chiara CamponovoThyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.ORCID 0000-0002-0678-3240
Elena GamarraThyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.ORCID 0000-0003-0483-7126
Lauro GianolaThyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.ORCID 0009-0008-4226-4131
Barbara LucchiniThyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Marco CentanniSapienza University of Rome, Department of Medical-Surgical Sciences and Biotechnologies, Latina, Italy.ORCID 0000-0003-0661-1649
Mario RotondiDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.ORCID 0000-0001-6464-2334
Camilla ViriliSapienza University of Rome, Department of Medical-Surgical Sciences and Biotechnologies, Latina, Italy.ORCID 0000-0002-4973-1950
Petra MakovacService of Surgery, Regional Hospital of Mendrisio, Ente Ospedaliero Cantonale, Mendrisio, Switzerland.ORCID 0000-0003-4252-4630

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDosing levothyroxine (LT4) in athyreotic patients after total thyroidectomy may appear straightforward to manage. However, robust evidence to guide therapy remains lacking. This study aimed to provide further information on the efficacy of fixed, weight-adjusted LT4 dosing initiated immediately after surgery. MATERIALS: Consecutive patients were enrolled at a single institution applying a standardized postoperative protocol: all cases initiated LT4 therapy immediately postoperatively at dose of ~1.6 mcg/kg, undergo their thyroid function test after six weeks, and receive subsequent dose adjustments until the target is reached.

resultsForty-eight patients met the inclusion criteria. The median LT4 starting dose was 100 mcg per day and 1.56 mcg/kg of body weight per day. At the first follow-up, 16 (33.3%) patients were at target. Over follow-up, the overall median time-to-target was 4 months. The 32 patients who reached the target later included 15 patients showing a decreased LT4 requirement and 17 patients with an increased LT4 need. The correlation analysis between body weight and LT4 dose revealed significant negative association between LT4 dose and weight variation (R² 0.18). In the multiple linear regression body weight and comorbidities were positively associated with LT4 dose on target, while age showed a negative association.

conclusionsEarly postoperative weight changes influence significantly LT4 dose requirements, and age and comorbidities provided additional predictive value. These findings highlight the need for early follow-up and LT4 titration in patients not at target after initial evaluation.

Indexed as

Body WeightHormone Replacement TherapyHypothyroidismPostoperative ComplicationsThyroidectomyThyroxineAdultAgedFemaleHumansMaleMiddle AgedTreatment OutcomeThyroxineDoseHypothyroidismLevothyroxineThyroidThyroidectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.